Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 22, Issue 30, Pages 6906
Publisher
Baishideng Publishing Group Inc.
Online
2016-08-08
DOI
10.3748/wjg.v22.i30.6906
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Looking up: Recent advances in understanding and treating peritoneal carcinomatosis
- (2015) Laura A. Lambert CA-A CANCER JOURNAL FOR CLINICIANS
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: A Systematic Review and Meta-analysis
- (2014) Joseph H. Helm et al. ANNALS OF SURGICAL ONCOLOGY
- Treatment of Microscopic Disease with Hyperthermic Intraoperative Intraperitoneal Chemotherapy After Complete Cytoreduction Improves Disease-Free Survival in Patients with Stage IIIC/IV Ovarian Cancer
- (2014) Pedro Antonio Cascales-Campos et al. ANNALS OF SURGICAL ONCOLOGY
- Cytoreductive Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study
- (2014) J. Spiliotis et al. ANNALS OF SURGICAL ONCOLOGY
- Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival for Patients with Peritoneal Carcinomatosis from Colorectal Cancer: A Phase II Study from a Chinese Center
- (2014) Chao-Qun Huang et al. PLoS One
- Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from colorectal cancer: A case-control study from a Chinese center
- (2013) Chao-Qun Huang et al. JOURNAL OF SURGICAL ONCOLOGY
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial
- (2011) Xiao-Jun Yang et al. ANNALS OF SURGICAL ONCOLOGY
- Carbohydrate antigen 242 highly consists with carbohydrate antigen 19-9 in diagnosis and prognosis of colorectal cancer: study on 185 cases
- (2011) Xue-Qin Yang et al. MEDICAL ONCOLOGY
- Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and/or peritoneal carcinomatosis: Results from a Chinese center
- (2010) Xiao-Jun Yang et al. JOURNAL OF SURGICAL ONCOLOGY
- Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer
- (2010) Xue-Qin Yang et al. MEDICAL ONCOLOGY
- The application of C12 biochip in the diagnosis and monitoring of colorectal cancer: Systematic evaluation and suggestion for improvement
- (2009) Y Li et al. Journal of Postgraduate Medicine
- Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival in Selected Patients with Peritoneal Carcinomatosis from Abdominal and Pelvic Malignancies: Results of 21 Cases
- (2008) Xiao-Jun Yang et al. ANNALS OF SURGICAL ONCOLOGY
- 8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer
- (2008) Vic J. Verwaal et al. ANNALS OF SURGICAL ONCOLOGY
- Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: A single western center experience
- (2008) S. Scaringi et al. EJSO
- Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei)
- (2008) Brendan Moran et al. JOURNAL OF SURGICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More